BME Stock Summary and Trading Ideas (Blackrock Health Sciences Trust | NYSE:BME)

BlackRock Health Sciences Trust’s (BME) (the “Trust”) investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Trust seeks to pursue this goal primarily by investing in a portfolio of equity securities and utilizing an option over-writing strategy in an effort to seek total return performance and enhance distributions. During the period, the Board of the Trust approved a change of the fiscal year of the Trust from October 31st to December 31st.

Blackrock Health Sciences Trust trades on the NYSE stock market under the symbol BME.

As of July 10, 2026, BME stock price declined to $43.01 with 21,649 million shares trading.

BME has a beta of 0.39, meaning it tends to be less sensitive to market movements. BME has a correlation of 0.10 to the broad based SPY ETF.

BME has a market cap of $555.87 million. This is considered a Small Cap stock.

In the last 3 years, BME traded as high as $44.35 and as low as $34.18.

BME has outperformed the market in the last year with a return of +25.5%, while the SPY ETF gained +21.8%. In the last 3 month period, BME beat the market returning +11.5%, while SPY returned +11.4%. However, in the most recent 2 weeks BME has underperformed the stock market by returning +1.4%, while SPY returned +3.6%.

BME support price is $42.92 and resistance is $44.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BME shares will trade within this expected range on the day.